Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology

One histological hallmark in Alzheimer's disease is the tangle. The other is the plaque. A widely discussed hypothesis is the "amyloid cascade" assuming that tangle formation is a direct consequence of amyloid plaque formation. The aim of this study was to examine plaques and tangles in a highly defined neuronal circuitry in order to determine their detailed spatial and temporal relationships. We investigated serial sections of the whole hippocampal formation of brains with early Braak-stages (0-III) for tangles only, i.e. one case at stage 0, six at stage I, six at stage II, and nine at stage III. Most cases displayed both plaques and tangles. Four cases of stages 0 and I, three cases with stage II, and even one with stage III, however, did not display plaques. In turn, no plaque was found in the absence of tangles. The spatial relationship indicates that plaques lay in the terminal fields of tangle-bearing neurons. Our analysis suggests that tangles either antecede plaques or--less likely--are independently formed.

[1]  J. Hardy,et al.  An ‘anatomical cascade hypothesis’ for Alzheimer's disease , 1992, Trends in Neurosciences.

[2]  C. Umilta Author's response to commentaries , 1996, Neurobiology of Aging.

[3]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[4]  L Seress,et al.  Interspecies comparison of the hippocampal formation shows increased emphasis on the regio superior in the Ammon's horn of the human brain. , 1988, Journal fur Hirnforschung.

[5]  H. Braak,et al.  Temporal Sequence of Alzheimer’s Disease-Related Pathology , 1999 .

[6]  R. Nitsch,et al.  Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic mice , 2001, Neuroreport.

[7]  R. Kalaria,et al.  Tau protein directly interacts with the amyloid β-protein precursor: Implications for Alzheimer's disease , 1995, Nature Medicine.

[8]  J Bohl,et al.  Spatial, Temporal and Numeric Analysis of Alzheimer Changes in the Nucleus Coeruleus , 1997, Neurobiology of Aging.

[9]  J. Morrison,et al.  Noradrenaline- and vasoactive intestinal peptide-containing neuronal systems in neocortex: Functional convergence with contrasting morphology , 1988, Neuroscience.

[10]  Brian J Cummings Plaques and Tangles: Searching for Primary Events in a Forest of Data , 1997, Neurobiology of Aging.

[11]  H. Buschke,et al.  Memory and mental status correlates of modified Braak staging , 1999, Neurobiology of Aging.

[12]  J. Price,et al.  Very mild Alzheimer's disease , 1991, Neurology.

[13]  K. Jellinger,et al.  Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients , 1993, Neuroscience Letters.

[14]  H. Braak,et al.  Alzheimer's disease: Mismatch between amyloid plaques and neuritic plaques , 1989, Neuroscience Letters.

[15]  J. Morris The Challenge of Characterizing Normal Brain Aging in Relation to Alzheimer’s Disease , 1997, Neurobiology of Aging.

[16]  H. Braak,et al.  Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease. , 1996, Neuroscience letters.

[17]  J. Price,et al.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease , 1991, Neurobiology of Aging.

[18]  H. Braak,et al.  The evolution of Alzheimer's disease‐related cytoskeletal pathology in the human raphe nuclei , 2000, Neuropathology and applied neurobiology.

[19]  J. Morris,et al.  Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.

[20]  Tangles and plaques in healthy aging and Alzheimer's disease: independence or interaction? , 1994 .

[21]  J. Busciglio,et al.  Presenilin-1 Mutations Reduce Cytoskeletal Association, Deregulate Neurite Growth, and Potentiate Neuronal Dystrophy and Tau Phosphorylation , 2001, The Journal of Neuroscience.

[22]  Henri M. Duvernoy The human hippocampus , 1988 .

[23]  E. Reusche,et al.  Comparison of silver stainings and immunohistology for the detection of neurofibrillary tangles and extracellular cerebral amyloid in paraffin sections , 2004, Acta Neuropathologica.

[24]  H. Braak,et al.  Age, neurofibrillary changes, Aβ-amyloid and the onset of Alzheimer's disease , 1996, Neuroscience Letters.

[25]  G. V. Van Hoesen,et al.  Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. , 1990, Progress in brain research.

[26]  E. Masliah,et al.  The Role of Synaptic Proteins in the Pathogenesis of Disorders of the Central Nervous System , 1993, Brain pathology.

[27]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[28]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[29]  H. Braak,et al.  Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes , 1995, Neuroscience.

[30]  H. Braak,et al.  A competition between silver-stain and immunocytochemistry , 1989 .

[31]  G. Perry,et al.  beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease. , 1996, The American journal of pathology.

[32]  J. Price,et al.  Cerebral amyloid deposition and diffuse plaques in ``normal'' aging , 1996, Neurology.

[33]  E. Mandelkow,et al.  Tau in Alzheimer's disease. , 1998, Trends in cell biology.

[34]  C. Duyckaerts,et al.  Alzheimer's lesions labelled by anti‐ubiquitin antibodies: comparison with other staining techniques. A study of 15 cases with graded intellectual status in ageing and Alzheimer's disease , 1993, Neuropathology and applied neurobiology.

[35]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.

[36]  H. Braak,et al.  Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert , 2000, Acta Neuropathologica.

[37]  P. Cras,et al.  Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease , 2004, Acta Neuropathologica.

[38]  J. Wegiel,et al.  Fibrillar amyloid-β affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration , 2001, Acta Neuropathologica.

[39]  J. Price,et al.  Formation of diffuse and fibrillar tangles in aging and early Alzheimer’s disease☆ , 2000, Neurobiology of Aging.

[40]  M. Bobinski,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[41]  N. Cairns,et al.  Alzheimer's disease: the relationship between the density of senile plaques, neurofibrillary tangles and A4 protein in human patients , 1991, Neuroscience Letters.

[42]  Hanns Ackermann,et al.  BIAS: a program package for biometrical analysis of samples , 1991 .

[43]  R. Armstrong,et al.  The distribution of senile plaques, neurofibrillary tangles and beta/A4 deposits in the hippocampus in Alzheimer's disease , 1992 .

[44]  P. Hof,et al.  Clinical validity of Braak neuropathological staging in the oldest-old , 2000, Acta Neuropathologica.

[45]  C. Duyckaerts,et al.  COMPARISON OF SEVEN STAINING METHODS FOR SENILE PLAQUES AND NEUROFIBRILLARY TANGLES IN A PROSPECTIVE SERIES OF 15 ELDERLY PATIENTS , 1989, Neuropathology and applied neurobiology.

[46]  D. Blum The Human Hippocampus , 1989, Neurology.